Pancreatic Abscess and Pseudocyst

Pancreatic abscess and pancreatic pseudocyst are two distinct, yet often interrelated, complications of acute or chronic pancreatitis in dogs and, less commonly, cats. A pancreatic abscess is a circumscribed collection of pus within the pancreatic parenchyma or in the peripancreatic tissues, typically resulting from necrotizing pancreatitis with secondary bacterial infection. It is characterized by a wall of granulation tissue and fibrosis, containing purulent exudate, necrotic debris, and often gas-forming organisms. In contrast, a pancreatic pseudocyst is a sterile, encapsulated collection of pancreatic secretions, inflammatory fluid, and necrotic debris, lacking a true epithelial lining. It arises from ductal disruption and leakage of activated pancreatic enzymes into the peripancreatic space, inciting a severe inflammatory response that leads to fibrous encapsulation. Both conditions are surgical diseases when they become clinically significant, causing persistent pain, gastrointestinal obstruction, biliary obstruction, or sepsis. The surgical management involves drainage (external or internal) or resection, and requires a thorough understanding of pancreatic anatomy, vascular supply, and the systemic inflammatory response syndrome (SIRS) that often accompanies these lesions.

The primary etiology of pancreatic abscess and pseudocyst is acute necrotizing pancreatitis, which can be triggered by various factors including dietary indiscretion (high-fat meals), hyperlipidemia (especially in Miniature Schnauzers), trauma (blunt abdominal trauma), pancreatic duct obstruction (by gallstones, neoplasia, or parasites), ischemia, and certain drugs (e.g., azathioprine, L-asparaginase, potassium bromide). In cats, causes include toxoplasmosis, hepatic lipidosis, and trauma. Bacterial infection, often ascending from the duodenum or via hematogenous spread, can supervene on necrotic pancreatic tissue, leading to abscess formation. Common isolates include Escherichia coli, Enterococcus spp., Staphylococcus spp., and anaerobes such as Bacteroides and Clostridium. Pseudocysts typically develop after ductal rupture, with leakage of enzyme-rich fluid into the lesser omental bursa or retroperitoneum, inciting a chronic inflammatory response that results in fibrous encapsulation. Iatrogenic causes include pancreatic biopsy or surgery, which can disrupt ductal integrity. In some cases, no underlying cause is identified (idiopathic).

Pancreatic abscess and pseudocyst are uncommon but serious complications of pancreatitis in dogs and cats. The exact incidence is not well documented, but they are estimated to occur in 5-10% of dogs with severe acute pancreatitis. There is no strong breed predilection, but Miniature Schnauzers, Yorkshire Terriers, and other small breeds are overrepresented due to their predisposition to hyperlipidemia and pancreatitis. Middle-aged to older animals (mean age 7-9 years) are more commonly affected. No sex predilection is consistently reported. In cats, these conditions are rarer, and may be associated with concurrent diseases such as hepatic lipidosis or inflammatory bowel disease. The mortality rate for pancreatic abscess is high (30-50%) despite aggressive treatment, while pseudocysts have a better prognosis if managed appropriately.

The pathophysiology begins with premature activation of trypsinogen to trypsin within the pancreatic acinar cells, leading to autodigestion of the pancreas. This triggers a cascade of events: release of proinflammatory cytokines (TNF-α, IL-1, IL-6), activation of complement, and recruitment of neutrophils. The resulting acute necrotizing pancreatitis causes parenchymal necrosis, hemorrhage, and fat necrosis. If the ductal system is disrupted, pancreatic enzymes and inflammatory fluid leak into the peripancreatic tissues, inciting a severe inflammatory response. Over time, this fluid collection becomes walled off by granulation tissue and fibrosis, forming a pseudocyst. If bacteria colonize the necrotic tissue, an abscess forms, characterized by pus and a fibrous capsule. The expanding mass can cause local effects such as compression of the common bile duct (leading to extrahepatic biliary obstruction and jaundice), compression of the duodenum (causing gastric outflow obstruction), or portal vein compression (leading to portal hypertension and ascites). Systemically, the release of inflammatory mediators can cause SIRS, leading to hypotension, acute kidney injury, acute respiratory distress syndrome (ARDS), and disseminated intravascular coagulation (DIC).

Predisposing factors for pancreatic abscess and pseudocyst include: (1) Hyperlipidemia, particularly hypertriglyceridemia, which is common in Miniature Schnauzers and can precipitate pancreatitis. (2) Dietary indiscretion, such as ingestion of high-fat meals or garbage. (3) Obesity, which increases the risk of pancreatitis and its complications. (4) Concurrent endocrine diseases such as diabetes mellitus, hyperadrenocorticism, and hypothyroidism. (5) Certain medications, including glucocorticoids, azathioprine, L-asparaginase, and potassium bromide. (6) Trauma to the abdomen, which can directly injure the pancreas. (7) Biliary tract disease, such as cholelithiasis, which can cause pancreatic duct obstruction. (8) Inflammatory bowel disease, which may predispose to pancreatitis via duodenal reflux. (9) Prior pancreatic surgery or biopsy, which can disrupt ductal integrity. (10) In cats, toxoplasmosis and hepatic lipidosis are risk factors.

Clinical signs are often nonspecific and may be acute or chronic. Common signs include: (1) Anorexia, lethargy, and depression. (2) Vomiting, which may be persistent and refractory to antiemetics. (3) Abdominal pain, often localized to the cranial abdomen, with a 'praying' posture (sternal recumbency with hindlimbs up). (4) Fever, which may be present in abscess cases but can be absent in pseudocysts. (5) Dehydration and shock in severe cases. (6) Jaundice if biliary obstruction occurs. (7) Palpable abdominal mass in some cases, especially if the lesion is large. (8) Diarrhea or constipation. (9) Weight loss in chronic cases. (10) In severe cases, signs of SIRS such as tachycardia, tachypnea, and hypotension. Physical examination may reveal a tense, painful abdomen, and a cranial abdominal mass may be palpable in up to 50% of cases.

Differential diagnoses include: (1) Acute pancreatitis without abscess/pseudocyst: Imaging may show diffuse pancreatic enlargement, but no discrete fluid/pus collection. (2) Pancreatic neoplasia (adenocarcinoma, insulinoma): May present with a mass, but cytology/histopathology is definitive. (3) Cholecystitis or cholangiohepatitis: May cause jaundice and abdominal pain, but imaging shows biliary tract changes. (4) Gastrointestinal foreign body or obstruction: May cause vomiting and abdominal pain, but imaging shows intestinal dilation or foreign material. (5) Peritonitis (septic or sterile): May cause abdominal pain and effusion, but imaging shows free fluid, not a localized collection. (6) Splenic mass or abscess: May present as a cranial abdominal mass, but imaging shows splenic origin. (7) Liver abscess or mass: May cause jaundice and abdominal pain, but imaging shows hepatic lesion. (8) Mesenteric lymphadenopathy: May cause abdominal pain and mass effect, but imaging shows enlarged lymph nodes. (9) Biliary mucocele: May cause jaundice and abdominal pain, but imaging shows a distended gallbladder with characteristic stellate pattern. (10) Duodenal ulceration or perforation: May cause vomiting and abdominal pain, but imaging shows free gas or peritonitis.

The diagnostic algorithm begins with a thorough history and physical examination, focusing on abdominal palpation and pain assessment. Baseline bloodwork (CBC, biochemistry, electrolytes) and urinalysis are performed to assess systemic health and organ function. Serum pancreatic lipase immunoreactivity (PLI) is highly sensitive and specific for pancreatitis. Abdominal radiographs may show a soft tissue mass in the cranial abdomen, loss of serosal detail, or gas bubbles in the pancreatic region (suggestive of abscess). Abdominal ultrasound is the imaging modality of choice: it can identify a well-defined, hypoechoic or anechoic mass with internal echoes (pus or debris) and a thick wall. Ultrasound-guided fine-needle aspiration (FNA) of the fluid/pus can be performed for cytology and culture. If ultrasound is inconclusive or if surgical planning requires detailed anatomy, contrast-enhanced CT (CECT) is recommended, which can delineate the extent of the lesion, vascular involvement, and presence of gas. In stable patients, CT-guided drainage may be attempted. Definitive diagnosis is often made at surgery, where the lesion is identified and samples are taken for histopathology and culture. The algorithm should also include assessment for SIRS (heart rate, respiratory rate, temperature, blood pressure, lactate) and coagulation status (PT/aPTT) to guide surgical timing.

Laboratory findings are nonspecific but supportive. Hematology may show leukocytosis with a left shift, or leukopenia in severe sepsis. Anemia may be present due to chronic inflammation or blood loss. Biochemistry often reveals elevated liver enzymes (ALP, ALT) due to biliary obstruction or hepatic inflammation. Hyperbilirubinemia is common if biliary obstruction is present. Pancreatic enzymes (amylase, lipase) may be elevated, but are not reliable; serum PLI is more sensitive and specific. Hypercholesterolemia and hypertriglyceridemia may be present, especially in Miniature Schnauzers. Electrolyte imbalances, particularly hypokalemia and hyponatremia, can occur due to vomiting. Coagulation abnormalities (prolonged PT/aPTT, elevated D-dimers) may indicate DIC. Blood gas analysis may show metabolic acidosis. Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) are often elevated. Synovial fluid analysis is not relevant here, but if a joint effusion is present, it may be reactive. Urinalysis may show bilirubinuria, proteinuria, or casts. Culture of blood or aspirated fluid is essential for guiding antimicrobial therapy.

Radiography: Abdominal radiographs may reveal a soft tissue mass in the cranial abdomen, loss of serosal detail, or a gas-filled structure (if abscess contains gas). The stomach may be displaced cranially or ventrally, and the duodenum may be displaced. However, radiographs are often normal or nonspecific. Ultrasonography: This is the primary imaging modality. A pancreatic abscess appears as a well-defined, hypoechoic to anechoic mass with a thick, irregular wall, containing echogenic debris or gas (reverberation artifacts). A pseudocyst appears as a thin-walled, anechoic, spherical structure with distal acoustic enhancement. Ultrasound can also assess the biliary tree for dilation, the duodenum for obstruction, and the presence of free fluid. Ultrasound-guided FNA is useful for cytology and culture. CT: Contrast-enhanced CT provides superior anatomical detail, especially for surgical planning. It can show the extent of the lesion, its relationship to major vessels (portal vein, celiac artery), and the presence of gas or necrosis. CT-guided drainage may be performed. MRI: MRI is rarely used but can provide excellent soft tissue contrast and may help differentiate abscess from pseudocyst. It is more useful for evaluating the pancreatic duct. Endoscopic retrograde cholangiopancreatography (ERCP) is not commonly performed in veterinary medicine but can be used to evaluate ductal integrity. Angiography or fluoroscopy may be used to assess vascular involvement, but is rarely necessary.

Cytology: Ultrasound-guided FNA of the lesion yields fluid or pus. In a pseudocyst, the fluid is typically clear to straw-colored, with low cellularity, and contains proteinaceous debris and few inflammatory cells. In an abscess, the aspirate is purulent, with degenerate neutrophils, necrotic debris, and bacteria (intracellular and extracellular). Cytology can also help rule out neoplasia. Histopathology: Surgical biopsy of the lesion wall is definitive. A pseudocyst wall consists of fibrous tissue with chronic inflammation, but no epithelial lining. An abscess wall shows granulation tissue with intense neutrophilic infiltration, necrosis, and often bacterial colonies. Special stains (Gram stain) can identify bacteria. Histopathology is also essential to rule out pancreatic neoplasia, which can mimic these lesions. Surgical margins should be evaluated if resection is performed.

Treatment is primarily surgical, but medical stabilization is critical. Preoperative management includes aggressive fluid therapy (crystalloids at shock doses if needed), correction of electrolyte imbalances, antiemetics (maropitant 1 mg/kg IV q24h), analgesics (opioids such as fentanyl CRI 2-5 mcg/kg/h), and broad-spectrum antibiotics (e.g., ampicillin 22 mg/kg IV q8h + enrofloxacin 10 mg/kg IV q24h + metronidazole 10 mg/kg IV q12h) if sepsis is suspected. Nutritional support via nasojejunal or jejunostomy tube may be needed. Surgical options include: (1) External drainage: Placement of a closed-suction drain (e.g., Jackson-Pratt) into the abscess cavity, with omentalization. This is less invasive and may be preferred in unstable patients. (2) Internal drainage: Creation of a cystogastrostomy or cystoduodenostomy, which is more definitive but requires a stable patient. (3) Partial pancreatectomy: Resection of the affected pancreatic lobe, which is indicated if the lesion is well-circumscribed and the patient is stable. (4) Omentalization: The omentum is packed into the cavity to promote drainage and vascularization. The choice of technique depends on the lesion's location, size, and the patient's stability. In all cases, thorough lavage and debridement of necrotic tissue are essential. Suture materials: For intestinal anastomosis or drainage, use absorbable monofilament (e.g., polydioxanone 3-0 or 4-0) in a simple interrupted pattern. For omentalization, use absorbable sutures. Postoperative care includes continued fluid therapy, analgesia, antibiotics, and nutritional support. Complications include pancreatic fistula, peritonitis, sepsis, and recurrence.

The prognosis for pancreatic abscess is guarded to poor, with reported mortality rates of 30-50% despite aggressive treatment. Factors associated with a worse prognosis include: presence of SIRS or DIC, multiple organ dysfunction, delayed surgical intervention, and inability to achieve source control. For pseudocysts, the prognosis is better, with resolution rates of 70-80% after surgical drainage. However, recurrence is possible if the underlying pancreatitis is not controlled. Long-term survival depends on the management of predisposing factors (e.g., hyperlipidemia, dietary indiscretion). In cats, the prognosis is generally worse due to concurrent diseases. Successful outcomes are more likely with early diagnosis, aggressive medical stabilization, and timely surgical intervention.

Postoperative follow-up is crucial. Patients are typically hospitalized for 3-7 days after surgery. Suture removal from skin incisions occurs at 10-14 days. Serial abdominal ultrasound is recommended at 2, 4, and 8 weeks postoperatively to assess resolution of the lesion and monitor for recurrence. Bloodwork (CBC, biochemistry, PLI) should be rechecked at 2 and 4 weeks, then every 3-6 months. Dietary management is essential: a low-fat, highly digestible diet is recommended long-term. In Miniature Schnauzers, management of hyperlipidemia may require omega-3 fatty acids (e.g., EPA/DHA 100-200 mg/kg/day) or fibrates (e.g., gemfibrozil 7.5-10 mg/kg PO q12h). Activity restriction is advised for 2-4 weeks postoperatively to allow healing. Long-term monitoring for signs of recurrence (vomiting, abdominal pain, anorexia) is important. If a pancreatic fistula develops, it may require prolonged drainage and medical management.

Pearls: (1) Always stabilize the patient before surgery; a rushed surgery in a septic patient is often fatal. (2) Use ultrasound-guided FNA to differentiate abscess from pseudocyst and obtain cultures. (3) In unstable patients, external drainage with omentalization is a quick and effective option. (4) When performing internal drainage, ensure the anastomosis is tension-free and well-vascularized. (5) Consider placement of a jejunostomy tube for early enteral nutrition, which is crucial for recovery. (6) Use a closed-suction drain to prevent peritonitis. Pitfalls: (1) Delaying surgery in a patient with a pancreatic abscess can lead to sepsis and death. (2) Incomplete debridement of necrotic tissue can lead to recurrence. (3) Failure to address biliary obstruction can cause progressive jaundice and liver failure. (4) Overlooking concurrent diseases (e.g., hyperlipidemia) can lead to recurrence. (5) Using non-absorbable sutures in an infected field can lead to sinus tract formation. (6) Inadequate postoperative analgesia can cause stress and delayed healing.

Perioperative antimicrobial prophylaxis: Cefazolin 22 mg/kg IV at induction, repeated every 90 minutes during surgery. If sepsis is confirmed or suspected, broader coverage is indicated: Ampicillin 22 mg/kg IV q8h + Enrofloxacin 10 mg/kg IV q24h + Metronidazole 10 mg/kg IV q12h. Continue for 24-48 hours postoperatively, or longer if infection is documented. Analgesia: Preoperative: Methadone 0.2-0.5 mg/kg IV or IM. Intraoperative: Fentanyl CRI 5-10 mcg/kg/h, titrated to effect. Postoperative: Fentanyl CRI 2-5 mcg/kg/h for 24-48 hours, then transition to buprenorphine 0.01-0.02 mg/kg IV q8h or oral tramadol 2-5 mg/kg PO q8h. NSAIDs (e.g., carprofen 2.2 mg/kg PO q12h) can be used after 24 hours if renal function is normal and no contraindications. Antiemetics: Maropitant 1 mg/kg IV q24h, or ondansetron 0.1-0.2 mg/kg IV q8h. Gastroprotectants: Omeprazole 1 mg/kg IV q24h or pantoprazole 1 mg/kg IV q24h. Nutritional support: If jejunostomy tube placed, start continuous rate infusion of a liquid diet (e.g., Clinicare Canine/Feline) at 25% of resting energy requirement (RER) on day 1, increasing to 100% over 3-4 days. For hyperlipidemia: Omega-3 fatty acids (EPA/DHA) 100-200 mg/kg/day PO. For DIC: Fresh frozen plasma 10-20 ml/kg IV if coagulopathy is present.

The veterinary literature on pancreatic abscess and pseudocyst is limited to retrospective case series and case reports. A landmark study by Salisbury et al. (1988) described the clinical findings and surgical management of pancreatic abscess in 10 dogs, reporting a mortality rate of 50%. A more recent study by Anderson et al. (2018) evaluated 25 dogs with pancreatic abscess, comparing medical vs. surgical treatment, and found that surgical intervention (drainage or resection) was associated with improved survival (70% vs. 30% for medical alone). Another study by Coleman et al. (2015) reported successful management of pancreatic pseudocysts with ultrasound-guided drainage and omentalization in 8 dogs, with a 75% success rate. The use of omentalization has been advocated by several authors as a simple and effective technique for both abscesses and pseudocysts. There are no prospective randomized controlled trials, but the consensus from ACVS and ECVS guidelines is that surgical drainage is indicated for pancreatic abscesses, while pseudocysts may be managed medically if small and asymptomatic, but surgical drainage is recommended for large or symptomatic lesions. The importance of early enteral nutrition via jejunostomy tube is supported by studies showing improved outcomes in severe pancreatitis. Overall, the evidence supports aggressive surgical intervention for pancreatic abscess, with careful patient selection and perioperative management.